- Home
- EU vs HUMA Comparison
EU vs HUMA Comparison
Compare EU & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EU
- HUMA
- Stock Information
- Founded
- EU 2009
- HUMA 2004
- Country
- EU United States
- HUMA United States
- Employees
- EU N/A
- HUMA N/A
- Industry
- EU Other Metals and Minerals
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- EU Basic Materials
- HUMA Health Care
- Exchange
- EU Nasdaq
- HUMA Nasdaq
- Market Cap
- EU 538.3M
- HUMA 367.6M
- IPO Year
- EU N/A
- HUMA N/A
- Fundamental
- Price
- EU $2.83
- HUMA $2.35
- Analyst Decision
- EU Strong Buy
- HUMA Strong Buy
- Analyst Count
- EU 1
- HUMA 7
- Target Price
- EU $2.75
- HUMA $13.00
- AVG Volume (30 Days)
- EU 3.5M
- HUMA 3.4M
- Earning Date
- EU 08-13-2025
- HUMA 08-12-2025
- Dividend Yield
- EU N/A
- HUMA N/A
- EPS Growth
- EU N/A
- HUMA N/A
- EPS
- EU N/A
- HUMA N/A
- Revenue
- EU $46,179,000.00
- HUMA $517,000.00
- Revenue This Year
- EU $27.46
- HUMA N/A
- Revenue Next Year
- EU $140.12
- HUMA $896.45
- P/E Ratio
- EU N/A
- HUMA N/A
- Revenue Growth
- EU N/A
- HUMA N/A
- 52 Week Low
- EU $1.01
- HUMA $1.15
- 52 Week High
- EU $4.44
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- EU 63.10
- HUMA 53.81
- Support Level
- EU $2.52
- HUMA $2.25
- Resistance Level
- EU $2.93
- HUMA $2.57
- Average True Range (ATR)
- EU 0.20
- HUMA 0.19
- MACD
- EU -0.02
- HUMA 0.01
- Stochastic Oscillator
- EU 75.00
- HUMA 49.65
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.